
FASB's ASC 815-40 indexation rewrite reopens the warrant test
A proposed ASU on indexation lands with comments due January 4, forcing technical accounting teams to judge equity-versus-liability classification for warrants and convertibles during year-end close.
FASB has reopened one of the most consequential and least loved corners of US GAAP. The board's ASC 815-40 indexation proposal, issued November 4, 2026, would change how companies evaluate whether settlement adjustments knock an instrument out of being indexed to the issuer's own stock. That single test decides whether a warrant sits quietly in equity or is remeasured to fair value through earnings every quarter, and comments are due January 4, 2027, squarely on top of FY2026 close.
What the proposal actually changes
The exposure draft, titled "Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Targeted Improvements to Indexation," aims at the step practitioners complain about most: assessing whether contractual settlement adjustments prevent an instrument from being considered indexed to an entity's own stock. PwC's accounting weekly news dated November 6 led with the draft and described it as a significant change to that evaluation.
FASB's own news release is unusually blunt about the status quo. The board says the existing indexation guidance is complex, costly to apply, and a frequent source of financial statement restatements. That is a rare admission in standard-setting language, and it signals the board is willing to trade some conceptual precision for a test that preparers and auditors can actually apply consistently.
The stakes are mechanical rather than philosophical. Equity classification keeps an instrument out of the income statement after issuance. Liability classification forces fair value remeasurement each period, injecting non-cash volatility into EPS and, in some capital structures, pressure on covenants written off GAAP net income.
Why this is the 2021 SPAC warrant episode in slow motion
Finance leaders who lived through 2021 need no reminder of what a reinterpretation of this guidance can do. A change in how settlement provisions were read against the indexation test converted hundreds of SPAC warrants from equity to liabilities and triggered a restatement wave that consumed technical accounting capacity for most of a year. Nothing about the underlying cash changed. The reported numbers changed anyway.
This proposal runs in the opposite direction. If the indexation test is simplified, some instruments currently carried as liabilities may qualify for equity treatment. That removes mark-to-market noise from earnings, which most CFOs would welcome. It also removes a line that sell-side models, covenant calculations and non-GAAP bridges have been built around, and that transition needs a communication plan rather than a footnote.
Timing sharpens the issue. Convertible and warrant-linked structures are being used heavily to fund capital expenditure programs right now. Instruments priced and papered in the current quarter may well be evaluated under revised guidance long before they mature.
A comment calendar that collides with close
The 60-day window is the practical problem. Technical accounting teams are expected to form a defensible position on indexation while simultaneously closing FY2026, and the queue behind it is crowded. Transfers and Servicing closed November 9. Cash Equivalents and Certain Digital Assets closed November 19. Consideration Payable to a Customer closed November 23. FASB separately proposed equity method changes on October 29.
Audit capacity is tight for a parallel reason. The SEC approved targeted amendments to QC 1000 on November 2, meaning firms are recalibrating quality control systems at the same moment that classification judgments are unsettled. Expect more documentation requests and less appetite for thinly supported conclusions on borderline instruments.
Companies that treat the comment letter as optional should at least be deliberate about it. Issuers with large or unusual equity-linked books have more to say about operability than almost anyone, and the board has signaled it is listening on cost and complexity.
The three-step playbook before January 4
First, inventory. Every outstanding equity-linked contract should be listed with its current classification and the specific settlement provisions that drove the conclusion: warrants, convertible notes, earnouts, SAFEs, down-round protected instruments and any embedded conversion features. Many companies discover their inventory lives in deal files rather than a maintained register.
Second, model. Run each instrument through the proposed test and quantify the difference. Where classification could flip from liability to equity, calculate the effect on historical and forward EPS, on covenant headroom, and on any incentive metric tied to GAAP net income. The point is not to pre-adopt but to know the size of the swing.
Third, decide on advocacy and on deal hygiene. Deal teams negotiating financing in the fourth and first quarters should understand that settlement terms drafted today may be judged under different guidance later, and should avoid exotic adjustment mechanics whose only justification is the current reading of the rules.
Key takeaways
- FASB's proposed ASU on Subtopic 815-40 indexation was issued November 4, 2026, with comments due January 4, 2027.
- The proposal targets whether settlement adjustments prevent an instrument from being indexed to the issuer's own stock, the step driving equity-versus-liability classification.
- FASB states the current guidance is complex, costly to apply and a frequent cause of restatements.
- Simplification could move some instruments from liability to equity, removing EPS volatility but changing a line investors already model.
- Inventory every equity-linked contract, model the classification swing, and brief deal teams before Q1 financings are papered.


